Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

Development of Spectrophotometric Method for the Quantitative Determination of Betamethasone 17-Valerate in Creams

04 July 2024, Version 2
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A simple spectrophotometric technique has been developed and validated for determination of betamethasone 17-valerate in pharmaceutical formulations. The method is based on cream dissolution in absolute ethanol and assaying spectrophotometrically at 240nm. The amount of betamethasone 17-valerate in cream was determined as 101.6 ± 0.0037 % w/w. The method validation demonstrated linearity for concentration range of 0.006mg/ml to 0.0014mg/ml (R2=0.9995). The method is simple and accurate and has successfully been employed in the analysis of some of Tripharm pharmaceutical formulations.

Keywords

HPLC
UV-Vis Spectroscopy
Betamethasone 17-Valerate

Supplementary materials

Title
Description
Actions
Title
Statistical calculations
Description
Statistical calculations for determining BV content in Cream Samples
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Version History

Jul 04, 2024 Version 2

Version Notes

The inclusion of the tittle, authors and affiliations in the supporting information document for better associations with the working paper submitted.

Metrics

53
7
0
Views
Downloads
Citations

License

CC logo
CC
BY logo
BY
The content is available under CC BY 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv-2024-tnstx-v2
D O I: 10.26434/chemrxiv-2024-tnstx-v2 [opens in a new tab]

Author’s competing interest statement

The author(s) have declared they have no conflict of interest with regard to this content

Ethics

The author(s) have declared ethics committee/IRB approval is not relevant to this content

Share